This antibody is a human immunoglobulin G4 (IgG4) monoclonal antibody (HuMAb), which can bind to the PD-1 receptor, blocking the interaction with PD-L1 and PD-L2, and prevent the tumor immunosuppressive response mediated by PD-1 pathway. This evidence concerns the gene CD274 and neoplasm.